Historically, improvement with antibiotics such as metronidazole or tylosin led to classification as antibiotic-responsive enteropathy.

Prepare for the Chronic Small Intestinal Disease Test with comprehensive multiple choice questions, detailed explanations, and helpful hints. Enhance your knowledge and get ready for your test!

Multiple Choice

Historically, improvement with antibiotics such as metronidazole or tylosin led to classification as antibiotic-responsive enteropathy.

Explanation:
Response to antibiotic therapy was historically used to categorize chronic enteropathies. When a patient with long-standing gastrointestinal symptoms showed marked improvement with antibiotics like metronidazole or tylosin, clinicians labeled the condition as antibiotic-responsive enteropathy. This reflected the idea that microbial factors or dysbiosis were driving the disease, and adjusting the bacterial environment could restore normal function. Metronidazole offers antimicrobial effects against certain bacteria and protozoa plus anti-inflammatory actions, while tylosin provides antibacterial activity and has beneficial effects on gut inflammation. While not every case fits perfectly—some improvements may arise from non-antibiotic actions or fluctuations—the historical pattern of improvement with these drugs justified the ARE classification.

Response to antibiotic therapy was historically used to categorize chronic enteropathies. When a patient with long-standing gastrointestinal symptoms showed marked improvement with antibiotics like metronidazole or tylosin, clinicians labeled the condition as antibiotic-responsive enteropathy. This reflected the idea that microbial factors or dysbiosis were driving the disease, and adjusting the bacterial environment could restore normal function. Metronidazole offers antimicrobial effects against certain bacteria and protozoa plus anti-inflammatory actions, while tylosin provides antibacterial activity and has beneficial effects on gut inflammation. While not every case fits perfectly—some improvements may arise from non-antibiotic actions or fluctuations—the historical pattern of improvement with these drugs justified the ARE classification.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy